SecBot SecBot
Insider Cluster (5 insiders) ·Filed Mar 2, 2026

BBNX

Beta Bionics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago
Insider cluster: 2 insiders, $23K total
Actionable Insight • Neutral

This cluster reflects routine post-grant selling behavior common in biotech firms. No immediate trading signal — monitor for larger-scale selling or fundamental changes in upcoming filings.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
BBNX ▼ -6.39% at T+60d
NEUTRAL call -6.39% · α vs SPY -15.72% · entry $12.52 → $11.72
Entry = T+0 close
Mar 1, 2026
via day close
T+1d
-7.59%
call -7.59% · α -6.67%
$11.57
settled 8mo ago
T+5d
-13.18%
call -13.18% · α -11.97%
$10.87
settled 8mo ago
T+20d
-21.25%
call -21.25% · α -13.31%
$9.86
settled 7mo ago
T+60d
-6.39%
call -6.39% · α -15.72%
$11.72
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Seven days of insider activity at Beta Bionics (BBNX) show coordinated open-market share sales by five C-suite executives totaling $96K, coinciding with a large non-cash stock grant to the same executives. The selling represents minimal economic value and is likely routine portfolio management following an equity award.

Key Financial Metrics

Direction
selling
Total Value
$96.6K
Insiders
5

Key Facts

  • Five C-suite executives sold shares in open-market transactions totaling $96,630 across 7,736 shares at ~$12.36 each on March 2, 2026.
  • On February 27, 2026, the same executives received substantial non-cash stock awards ranging from 109,105 to 343,269 shares, likely part of a compensation package.
  • Total open-market selling volume ($96K) represents only 0.017% of BBNX's $556M market cap — well below materiality threshold.
  • All transactions occurred within a 7-day window, suggesting planned activity around the equity grant date.

Financial Impact

$96,630 in open-market sales; no financial impact from non-cash grants

insider ownershippotential sentiment perception

Risk Factors

  • Perception risk if investors misinterpret coordinated selling as lack of confidence, despite likely routine nature.
  • Future dilution possible from newly granted shares, though not immediate.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (10 trades, 7d window)cluster-BBNX-1772581550954
24 reports for BBNX
Performance horizon
56% Hit rate @ T+20 5 of 9 directional calls Went positive at some point 8 of 9 best @ T+60▲ +41.72%Apr 21, 2026
Filters
Rows
Reports for BBNX — sortable, filterable
TypeNow
Oct 27, 2026
today
8-K
NEUTRAL ★ 5/10
$20.50awaiting T+20—$21.39 (+4.34%)
Oct 27, 2026
today
Press Release
MIXED ★ 6/10
$20.27awaiting T+20—$21.39 (+5.53%)
Oct 7, 2026
20d ago
SC 13G
NEUTRAL ★ 4/10
$18.08awaiting T+20—$21.39 (+18.31%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$21.76 $19.34▲ +11.12%▲ +10.70%$21.39 (+1.70%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$22.04 $16.84▲ +23.59%▲ +22.69%$21.39 (+2.95%)
Sep 17, 2026
5w ago
Press Release
NEUTRAL ★ 5/10
$21.89 $16.35▼ −25.31%▼ −25.51%$21.39 (−2.28%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$21.89 $16.35▼ −25.31%▼ −25.51%$21.39 (−2.28%)
Sep 15, 2026
5w ago
Press Release
BEARISH ★ 6/10
$22.18 $16.87▲ +23.94%▲ +26.00%$21.39 (+3.56%)
Sep 15, 2026
6w ago
8-K
BULLISH ★ 7/10
$22.18 $16.87▼ −23.94%▼ −26.00%$21.39 (−3.56%)
Sep 15, 2026
6w ago
Press Release
BEARISH ★ 6/10
$22.18 $16.87▲ +23.94%▲ +26.00%$21.39 (+3.56%)
Showing 10 of 24

US Market Status

Market Closed — Opens Thu (11h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 3, 2026